Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Interest Coverage Ratio (2010 - 2026)

Incyte's (INCY) quarterly Interest Coverage Ratio came in at 110.78 in Q2 2026, up 19.07% YoY from 93.04 in Q2 2025, and up 135.45% on a QoQ basis from 47.05 in Q1 2026.

Analysis

Incyte (INCY) Interest Coverage Ratio (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Interest Coverage Ratio data on file, last reported at 110.78 in Q2 2026.

  • Quarterly Interest Coverage Ratio rose 19.07% year-over-year to 110.78 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1125.56 (down 2145.48% YoY) and the FY2025 annual result came in at 67.63, up 235699.99% from the prior year.
  • Interest Coverage Ratio rose to 110.78 in Q2 2026, from 47.05 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 749.19 in Q3 2025 to a low of 91.95 in Q2 2024.
  • A 5-year average of 73.29 and a median of 39.16 in 2023 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2024 — Interest Coverage Ratio slumped 289.8% — and 2025, when it surged 2566.78%.
  • Tracing INCY's Interest Coverage Ratio over 5 years: stood at 105.09 in 2022, then slumped by 114.79% to 15.54 in 2023, then surged by 504.15% to 62.82 in 2024, then sank by 135.95% to 22.58 in 2025, then jumped by 590.53% to 110.78 in 2026.
  • The last three Interest Coverage Ratio figures came in at 110.78 (Q2 2026), 47.05 (Q1 2026), and 22.58 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 1,199.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,199.14
Mar 31, 2026 529.20
Dec 31, 2025 577.08
Sep 30, 2025 749.19
Jun 30, 2025 892.78
Mar 31, 2025 310.86
Dec 31, 2024 719.60
Sep 30, 2024 188.74
Jun 30, 2024 -727.75
Mar 31, 2024 213.72
Dec 31, 2023 232.92
Sep 30, 2023 344.63
Jun 30, 2023 295.85
Mar 31, 2023 52.81
Dec 31, 2022 105.09
Sep 30, 2022 215.88
Jun 30, 2022 375.27
Mar 31, 2022 171.38
Dec 31, 2021 147.25
Sep 30, 2021 536.24